Ratings ASR Nederland CINNOBER BOAT

Equities

0RHS

NL0011872643

Delayed CINNOBER BOAT Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-.--%

03-18	ASR Nederland N.V.(ENXTAM:ASRNL) added to S&P International 700	CI
03-18	ASR Nederland N.V.(ENXTAM:ASRNL) added to S&P EUROPE 350 - Insurance (Industry Group)	CI

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

Its low valuation, with P/E ratio at 8.75 and 8.26 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company's share price in relation to its net book value makes it look relatively cheap.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
This company will be of major interest to investors in search of a high dividend stock.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Sector: Multiline Insurance & Brokers

	1st Jan change	Capi.	ESG Refinitiv
ASR NEDERLAND	-.--%	9.82B	-
CHUBB LIMITED	+14.81%	109B	C+
ALLIANZ SE	+4.73%	105B	B-
MARSH & MCLENNAN COMPANIES	+10.24%	103B	B
ZURICH INSURANCE GROUP LTD	+7.23%	76.16B	C+
HARTFORD FINANCIAL SERVICES GROUP (THE), INC.	+23.75%	29.42B	A-
TALANX AG	+10.75%	19.76B	A-
BB SEGURIDADE PARTICIPAÇÕES S.A.	-3.54%	11.92B	B-
ICICI LOMBARD GENERAL INSURANCE COMPANY LIMITED	+21.89%	10.22B	A-
POWSZECHNY ZAKLAD UBEZPIECZE? SPÓLKA AKCYJNA	+2.26%	10.2B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes